Sign in

AbCellera Biologics Inc.

Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18
Total revenue 0.08 0.03 0.04 0.49 0.01 0.23 0.01 0.01
Cost of revenue 0.03 0.10 0.03 0.07 0.05 0.03 0.01 0.01
Gross profit 0.05 0.03 0.04 0.42 0.01 0.21 0.01 0.01
Total operating expenses + 0.26 0.34 0.28 0.20 0.01 0.05 0.02 0.01
Operating income -0.22 -0.31 -0.24 0.22 0.00 0.16 0.00 0.00
Non-operating income (net) 0.04 0.11 0.06 0.02 0.00 0.00 0.00 0.00
Income before tax -0.18 -0.20 -0.17 0.24 0.00 0.16 0.00 0.00
Income tax expense -0.03 -0.04 -0.03 0.08 0.07 0.04 0.00 0.00
Net income -0.15 -0.16 -0.15 0.16 0.00 0.12 0.00 0.00
Show Quarterly Income Statement
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23 Dec-22 Sep-22 Jun-22 Mar-22 Dec-21 Sep-21 Jun-21 Mar-21 Dec-20 Sep-20 Jun-20 Mar-20 Dec-19 Sep-19 Jun-19 Mar-19
Total revenue 0.01 0.04 0.01 0.02 0.00 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.02 0.10 0.05 0.32 0.14 0.01 0.03 0.20 0.21 0.01 0.01 0.00 0.00 0.00 0.00 0.00
Cost of revenue 0.01 0.01 0.01 0.04 0.01 0.04 0.04 0.01 0.01 0.01 0.01 0.05 0.00 0.02 0.01 0.04 0.02 0.02 0.00 0.02 0.04 0.01 0.01 0.00 0.00 0.00 0.00 0.00
Gross profit 0.00 0.04 0.01 0.02 0.00 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.02 0.09 0.04 0.27 0.12 0.01 0.02 0.18 0.21 0.01 0.01 0.00 0.00 0.00 0.00 0.00
Total operating expenses + 0.06 0.07 0.09 0.07 0.07 0.08 0.10 0.10 0.06 0.08 0.06 0.06 0.08 0.06 0.05 0.05 0.05 0.04 0.03 0.03 0.02 0.05 0.01 0.01 0.01 0.01 0.00 0.00 0.00
Operating income -0.06 -0.03 -0.08 -0.05 -0.06 -0.07 -0.09 -0.09 -0.05 -0.07 -0.05 -0.05 -0.06 -0.04 0.04 -0.01 0.22 0.08 -0.03 -0.01 0.16 0.16 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Non-operating income (net) 0.01 0.01 0.01 0.01 0.01 0.03 0.03 0.05 0.01 0.02 0.02 0.01 0.02 0.01 0.01 0.00 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.00
Income before tax -0.05 -0.02 -0.07 -0.04 -0.05 -0.05 -0.06 -0.05 -0.04 -0.05 -0.04 -0.04 -0.05 -0.03 0.05 -0.01 0.23 0.08 -0.02 0.00 0.16 0.16 0.00 0.01 0.00 0.00 0.00 0.00 0.00
Income tax expense -0.01 -0.01 -0.01 0.00 -0.01 -0.01 -0.01 -0.01 0.00 0.00 -0.01 -0.01 -0.01 0.00 0.02 0.00 0.06 0.02 0.00 0.00 0.04 0.04 0.00 0.00
Net income -0.04 -0.01 -0.06 -0.03 -0.05 -0.03 -0.05 -0.04 -0.04 -0.05 -0.03 -0.03 -0.04 -0.03 0.03 -0.01 0.17 0.06 -0.02 0.00 0.12 0.12 0.00 0.01 0.00 0.00 0.00 0.00 0.00
4 days ago
Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18
Total cash and short-term investments + 0.53 0.63 0.76 0.89 0.72 1.19 0.01 0.01
Accounts receivable, net 0.15 0.09 0.06 0.04 0.16 0.21 0.00 0.00
Inventories 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other current assets 0.03 0.03 0.05 0.10 0.04 0.00 0.00 0.00
Total current assets 0.73 0.75 0.87 1.03 0.93 0.81 0.01 0.02
Total non-current assets + 0.63 0.61 0.62 0.52 0.39 0.19 0.01 0.01
Total assets 1.36 1.36 1.49 1.54 1.32 1.01 0.02 0.02
Total current liabilities + 0.06 0.08 0.12 0.12 0.12 0.10 0.01 0.01
Total non-current liabilities + 0.33 0.23 0.22 0.19 0.17 0.07 0.01 0.00
Total liabilities 0.39 0.30 0.34 0.31 0.29 0.18 0.01 0.01
Total stockholders' equity + 0.97 1.06 1.15 1.23 1.03 0.83 0.01 0.01
Common shares outstanding 299 294 289 315 318 263 238 151
Show Quarterly Balance Sheet
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23 Dec-22 Sep-22 Jun-22 Mar-22 Dec-21 Sep-21 Jun-21 Mar-21 Dec-20 Sep-20 Jun-20 Mar-20 Dec-19 Sep-19 Jun-19 Mar-19
Total cash and short-term investments + 0.50 0.53 0.50 0.55 0.61 0.63 0.64 0.67 0.70 0.76 0.79 0.80 0.80 0.89 0.87 1.02 0.79 0.72 0.75 0.84 0.72 0.59 0.69 0.13 0.01 0.60 0.00 0.00 0.01
Accounts receivable, net 0.12 0.15 0.16 0.15 0.13 0.09 0.06 0.07 0.07 0.06 0.08 0.09 0.10 0.10 0.11 0.05 0.33 0.16 0.04 0.07 0.02 0.21 0.01 0.00 0.01 0.00
Inventories 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.03 0.03 0.03 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other current assets 0.04 0.03 0.04 0.04 0.03 0.03 0.04 0.03 0.05 0.05 0.06 0.05 0.04 0.03 0.05 0.04 0.03 0.04 0.01 0.00 0.20 0.00 0.02 0.02 0.00
Total current assets 0.66 0.73 0.70 0.74 0.76 0.75 0.74 0.77 0.81 0.87 0.92 0.93 0.94 1.03 1.05 1.14 1.17 0.93 0.80 0.86 0.91 0.81 0.11 0.13 0.01 0.01 0.01
Total non-current assets + 0.64 0.63 0.66 0.66 0.58 0.61 0.65 0.64 0.65 0.62 0.59 0.61 0.56 0.52 0.51 0.45 0.42 0.39 0.37 0.29 0.22 0.19 0.03 0.03 -0.01 0.01 -0.01
Total assets 1.31 1.36 1.36 1.40 1.34 1.36 1.39 1.41 1.46 1.49 1.51 1.54 1.50 1.54 1.55 1.59 1.59 1.32 1.17 1.15 1.13 1.01 0.14 0.16 0.02
Total current liabilities + 0.05 0.06 0.07 0.07 0.08 0.08 0.08 0.07 0.10 0.12 0.11 0.12 0.09 0.12 0.11 0.22 0.21 0.12 0.05 0.07 0.09 0.10 0.02 0.02 0.02 0.01
Total non-current liabilities + 0.32 0.33 0.32 0.33 0.25 0.23 0.24 0.23 0.23 0.22 0.22 0.22 0.20 0.19 0.20 0.16 0.17 0.17 0.17 0.11 0.08 0.07 0.03 0.05 0.01
Total liabilities 0.37 0.39 0.39 0.39 0.32 0.30 0.31 0.30 0.33 0.34 0.33 0.34 0.29 0.31 0.30 0.38 0.38 0.29 0.22 0.18 0.17 0.18 0.05 0.06 0.01
Total stockholders' equity + 0.94 0.97 0.96 1.01 1.02 1.06 1.08 1.11 1.13 1.15 1.18 1.19 1.21 1.23 1.25 1.21 1.21 1.03 0.95 0.97 0.96 0.83 0.09 0.09 0.01 0.01 0.01
Common shares outstanding 303 299 299 299 298 295 295 294 293 291 289 289 288 301 316 285 311 315 279 272 320 320 266 238 238 238 152 151 151
4 days ago
Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18
Operating cash flow + -0.13 -0.11 -0.04 0.28 0.24 0.02 0.00 0.00
Cash flow from investing + 0.09 0.12 -0.22 -0.35 -0.33 -0.12 -0.01 -0.01
Cash flow from financing + 0.01 0.01 0.01 0.00 0.00 0.68 0.00 0.01
Change in cash -0.03 0.03 -0.25 -0.08 -0.09 0.59 0.00 0.01
Show Quarterly Cash Flow
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23 Dec-22 Sep-22 Jun-22 Mar-22 Dec-21 Sep-21 Jun-21 Mar-21 Dec-20 Sep-20 Jun-20 Mar-20 Dec-19 Sep-19 Jun-19 Mar-19
Operating cash flow + -0.03 -0.03 -0.05 -0.03 -0.01 -0.01 -0.03 -0.03 -0.04 -0.02 0.00 0.02 -0.04 0.03 -0.13 0.27 0.10 -0.02 -0.01 0.16 0.11 0.00 0.00 0.03 0.00 0.00 0.00 0.00 0.00
Cash flow from investing + -0.03 0.08 0.04 -0.03 0.01 0.04 0.00 0.05 0.03 -0.02 -0.01 -0.04 -0.15 -0.02 -0.28 -0.03 -0.03 0.00 -0.27 -0.05 -0.02 -0.11 0.00 0.00 -0.01 0.00 0.00 0.00 0.00
Cash flow from financing + 0.01 0.00 0.01 0.00 0.01 0.00 0.00 0.00 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.01 0.00 0.63 -0.01 0.00 0.09 0.00 0.00 0.00 0.00
Change in cash -0.05 0.04 -0.01 -0.07 0.00 0.03 -0.02 0.02 -0.01 -0.04 -0.01 -0.01 -0.19 0.01 -0.41 0.25 0.07 -0.02 -0.27 0.11 0.09 0.52 -0.02 0.02 0.08 0.00 0.00 0.00 0.00
4 days ago

AbCellera Biologics Inc. (ABCL) - Depreciation And Amortization

1Y 2Y 5Y Max
9 days ago

AbCellera Biologics Inc. (ABCL) - Interest Income

1Y 2Y 5Y Max
9 days ago

AbCellera Biologics Inc. (ABCL) - Net Interest Income

1Y 2Y 5Y Max
9 days ago

AbCellera Biologics Inc. (ABCL) - Operating Expenses

1Y 2Y 5Y Max
9 days ago

AbCellera Biologics Inc. (ABCL) - Research And Development

1Y 2Y 5Y Max
9 days ago

AbCellera Biologics Inc. (ABCL) - Selling General And Administrative

1Y 2Y 5Y Max
9 days ago

AbCellera Biologics Inc. (ABCL) - Operating Income

1Y 2Y 5Y Max
9 days ago

AbCellera Biologics Inc. (ABCL) - Costof Goods And Services Sold

1Y 2Y 5Y Max
9 days ago

AbCellera Biologics Inc. (ABCL) - Cost Of Revenue

1Y 2Y 5Y Max
9 days ago

AbCellera Biologics Inc. (ABCL) - Total Revenue

1Y 2Y 5Y Max
9 days ago